1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Eclampsia: new trials by email Literature Review of Eclampsia trials Research Report on Eclampsia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial labetalol (seizure prevention), MgSO4 (seizure prevention) - Preeclampsia, Pregnancy Induced Hypertension | Phase 2 / Phase 3 | Withdrawn | Baylor College of Medicine | 2015-06-01 | 2017-01-13 | |
| Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. Labetalol, Hydralazine - Hypertension, Pregnancy Induced, Hydralazine Adverse Reaction | Phase 2 | Completed | Dow University of Health Sciences | 190 | 2012-10-01 | 2018-10-26 |
Hypertension, Pregnancy-Induced (2) · Pre-Eclampsia (2) · HELLP Syndrome (1) · Hypertension (1) · Seizures (1)
Cardiovascular Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Pregnancy Complications (2) · Urogenital Diseases (2) · Vascular Diseases (2) · Hypertension (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Labetalol (2) · Hydralazine (1)
Baylor College of Medicine (1) · Dow University of Health Sciences (1)
India (1) · Pakistan (1) · United States (1)
Michael A Belfort, MD, PhD (1) · Nazeer Khan, PhD (1) · Saima A Siddiqui, MCPS,FCPS (1)